mek-162
Showing 1 - 1 of 1
Leukemia Trial in Houston (MEK-162, Nilotinib, Questionnaires)
Terminated
- Leukemia
- MEK-162
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 10, 2020